Exploring the Antitumor Mechanisms of Zingiberis Rhizoma Combined with Coptidis Rhizoma Using a Network Pharmacology Approach

<div>Partial view of molecular docking. (a) Berberine and AKT1 (binding free energy: −88.58 kCal/mol), (b) berberine and TP53 (binding free energy: −62.173 kCal/mol), and (c) quercetin and EGFR (binding free energy: −126.111 kCal/mol).</div>

BioMed Research International

fig11

Figure 11

Figure 11: Exploring the Antitumor Mechanisms of Zingiberis Rhizoma Combined with Coptidis Rhizoma Using a Network Pharmacology Approach 